Alsevalimab (Anti-B7-H4 / VTCN1)

Alsevalimab (Anti-B7-H4 / VTCN1) is a human monoclonal antibody targeting B7-H4. It has potential antineoplastic and immune checkpoint inhibitory activities. MW :144.74 KD.
Supplier Selleck Chemicals
Product # A2597
Sku # A2597-1mg
Pricing 1mg, $370.00
Feedback